| Product name | Recombinant SARS-CoV-2 envelope Protein with His and Avi tag |
|---|---|
| Catalog No. | RP01263 |
| Description | Recombinant SARS-CoV-2(2019-nCoV) envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2(2019-nCoV) envelope (Accession #QHD43418.1) fused with an initial Met, a 6×His, Avi tag at the N-terminus. |
| Bio-Activity | Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Envelope at 2μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid with a linear range of 1.2-41.1 ng/mL. |
| Purity | > 95% by SDS-PAGE. |
| Endotoxin | < 0.1 EU/μg of the protein by LAL method. |
| Formulation | Supplied as a 0.22 μm filtered solution in 20mM Tris, 250mM NaCl, 0.5%TritonX-100, pH 8.0.Contact us for customized product form or formulation. |
| Species | SARS-CoV-2 |
| Calculated MW | 11.4kDa |
| Synonym | 2019-nCoV E protein; 2019-nCoV sM protein; Envelope protein; Env polyprotein; Envelope glycoprotein; env; COVID-19; E |
|---|---|
| Expression Host | E. coli |
| Tag | N-6×His & Avi |
| Gene ID |
| Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
Publishing research using RP01263? Please let us know so that we can cite the reference in this datasheet.
!OUT OF STOCK
See Below for Alternatives
